ImmunoStar Inc
ImmunoStar has been a pioneer in the field of antibody manufacturing since 1975. As the original manufacturer of primary antibodies, ImmunoStar supports and empower neuroscientists around the globe, providing tools that are essential for the exploration and understanding of the complex world of neuroscience.
They offer high-titer antibodies at fair prices, and each of these antibodies has been specifically tested for use in immunohistochemistry.
More about ImmunoStar
Over the years, ImmunoStar has built a solid reputation for providing trusted antibodies and the has been cited in over seven thousand publications, reflecting their widespread use and acceptance in the biomedical research field.
ImmunoStar’s core antibodies have been instrumental in advancing research in various neurological disorders, including Parkinson’s disease, Alzheimer’s abnormalities, epilepsy, schizophrenia, Lou Gehrig’s disease, and Huntington’s disease. Additionally, their products have contributed to the understanding of opiate receptors, which may lead to improved treatments for conditions such as alcoholism and rheumatoid arthritis.
With a dedicated scientific team, ImmunoStar ensures rigorous quality-control testing for lot-to-lot consistency, which has cemented their products’ excellent reputation among neuroscience researchers. The company’s dedication to quality and reliability was recognized when they received CiteAb’s 2014 Small Company of the Year award, highlighting the highest number of citations per antibody.